| Primary |
| Diabetes Mellitus |
38.2% |
| Type 2 Diabetes Mellitus |
22.8% |
| Product Used For Unknown Indication |
10.0% |
| Hypertension |
6.3% |
| Diabetes Mellitus Non-insulin-dependent |
5.0% |
| Drug Use For Unknown Indication |
4.4% |
| Blood Glucose Increased |
2.2% |
| Blood Pressure Abnormal |
1.5% |
| Blood Glucose Abnormal |
1.4% |
| Ill-defined Disorder |
1.3% |
| Blood Cholesterol Increased |
1.1% |
| Accidental Poisoning |
0.9% |
| Blood Cholesterol Abnormal |
0.7% |
| Hepatitis C |
0.7% |
| Blood Pressure |
0.6% |
| Cardiac Disorder |
0.6% |
| Osteoarthritis |
0.6% |
| Thyroid Disorder |
0.6% |
| Hypoglycaemia |
0.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.5% |
|
| Hypoglycaemia |
23.2% |
| Blood Glucose Increased |
18.1% |
| Drug Ineffective |
8.7% |
| Blood Glucose Decreased |
5.1% |
| Weight Increased |
4.3% |
| Diabetes Mellitus Inadequate Control |
3.6% |
| Loss Of Consciousness |
3.2% |
| Completed Suicide |
3.0% |
| Medication Residue |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Vomiting |
3.0% |
| Death |
2.8% |
| Rash |
2.8% |
| Vision Blurred |
2.6% |
| Diarrhoea |
2.3% |
| Mental Status Changes |
2.3% |
| Unresponsive To Stimuli |
2.3% |
| Weight Decreased |
2.3% |
| Malaise |
2.1% |
| Syncope |
2.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
23.1% |
| Diabetes Mellitus |
19.7% |
| Drug Use For Unknown Indication |
19.2% |
| Product Used For Unknown Indication |
16.8% |
| Hypertension |
6.5% |
| Diabetes Mellitus Non-insulin-dependent |
2.2% |
| Blood Cholesterol Increased |
1.9% |
| Osteoarthritis |
1.1% |
| Hyperlipidaemia |
1.1% |
| Diabetic Neuropathy |
1.0% |
| Depression |
0.9% |
| Oedema |
0.9% |
| Blood Glucose Abnormal |
0.8% |
| Alanine Aminotransferase Increased |
0.8% |
| Cardiac Disorder |
0.8% |
| Smoking Cessation Therapy |
0.7% |
| Completed Suicide |
0.6% |
| Oedema Peripheral |
0.6% |
| Hepatic Enzyme Increased |
0.6% |
| Ill-defined Disorder |
0.6% |
|
| Completed Suicide |
16.4% |
| Blood Glucose Increased |
12.9% |
| Weight Increased |
8.5% |
| Death |
7.1% |
| Hypoglycaemia |
5.9% |
| Weight Decreased |
5.0% |
| Drug Ineffective |
4.6% |
| Tremor |
4.6% |
| Visual Impairment |
4.0% |
| Renal Failure Acute |
3.6% |
| Vomiting |
3.6% |
| Poisoning |
3.2% |
| Rash |
3.0% |
| Vision Blurred |
3.0% |
| Blood Glucose Decreased |
2.8% |
| Blood Glucose Fluctuation |
2.6% |
| Cardiac Disorder |
2.4% |
| Drug Toxicity |
2.4% |
| Pain In Extremity |
2.4% |
| Respiratory Arrest |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
15.9% |
| Diabetes Mellitus |
14.1% |
| Type 2 Diabetes Mellitus |
11.2% |
| Hypertension |
7.9% |
| Diabetes Mellitus Non-insulin-dependent |
4.2% |
| Blood Cholesterol Increased |
3.0% |
| Pain |
2.4% |
| Depression |
2.2% |
| Rheumatoid Arthritis |
1.9% |
| Multiple Myeloma |
1.5% |
| Atrial Fibrillation |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Prophylaxis |
1.2% |
| Cardiac Disorder |
1.2% |
| Blood Pressure |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Asthma |
1.2% |
| Anxiety |
1.2% |
| Blood Cholesterol |
1.0% |
|
| Weight Decreased |
22.3% |
| Vomiting |
11.0% |
| Blood Glucose Increased |
9.9% |
| Nausea |
6.8% |
| Weight Increased |
6.3% |
| Drug Ineffective |
4.8% |
| Myocardial Infarction |
4.8% |
| Tremor |
3.7% |
| Death |
3.5% |
| Pain |
2.9% |
| Pancreatitis |
2.9% |
| Type 2 Diabetes Mellitus |
2.8% |
| Vision Blurred |
2.6% |
| Flushing |
2.4% |
| Renal Failure Acute |
2.3% |
| Injection Site Pain |
2.3% |
| Pneumonia |
2.2% |
| Renal Failure |
2.2% |
| Oedema Peripheral |
2.2% |
| Urinary Tract Infection |
2.2% |
|
| Interacting |
| Diabetes Mellitus |
17.1% |
| Depression |
12.4% |
| Hypertension |
12.0% |
| Product Used For Unknown Indication |
8.8% |
| Type 2 Diabetes Mellitus |
7.8% |
| Tachyarrhythmia |
6.5% |
| Drug Use For Unknown Indication |
5.5% |
| Blood Cholesterol Increased |
3.7% |
| Hyperlipidaemia |
3.7% |
| Dyslipidaemia |
3.2% |
| High Density Lipoprotein Decreased |
2.8% |
| Urinary Tract Infection |
2.3% |
| Cardiac Failure Congestive |
1.8% |
| Constipation |
1.8% |
| Convulsion |
1.8% |
| Diabetes |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hypothyroidism |
1.8% |
| Psychotic Disorder |
1.8% |
| Adverse Event |
1.4% |
|
| Myocardial Infarction |
17.5% |
| Weight Increased |
12.5% |
| Drug Interaction |
10.0% |
| Hypoglycaemia |
10.0% |
| Tremor |
10.0% |
| Wrist Fracture |
7.5% |
| Pain In Extremity |
5.0% |
| Pancytopenia |
5.0% |
| Prostate Cancer |
5.0% |
| Chills |
2.5% |
| Fatigue |
2.5% |
| Pyrexia |
2.5% |
| Renal Failure |
2.5% |
| Stupor |
2.5% |
| Tooth Loss |
2.5% |
| Vision Blurred |
2.5% |
|
